Edesa Biotech, Inc. (EDSA) › Net IncomeEdesa Biotech, Inc. (EDSA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$5.53M2013: -$14.50M2014: -$8.44M2015: -$2.84M2016: -$5.03M2017: -$5.03M2018: -$1.54M2020: -$6.36M2021: -$13.34M2022: -$17.55M2023: -$8.37M2024: -$6.17M2025: -$7.19M-$7.19M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$7.19M-16.5%2024-$6.17M+26.3%2023-$8.37M+52.3%2022-$17.55M-31.5%2021-$13.34M-109.7%2020-$6.36M—2018-$1.54M+69.5%2017-$5.03M-0.1%2016-$5.03M-76.8%2015-$2.84M+66.3%2014-$8.44M+41.8%2013-$14.50M-162.2%2012-$5.53M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share